Vidcast:  https://youtu.be/-aGBPfpbDTo

 

The Harvard Medical School spinoff Surge Therapeutics has captured a $26 million war chest to begin testing its intraoperative immunotherapy hydrogel strategy in human patients.  Their successful mouse studies cured aggressive cancers with a single dose of the gel and, hopefully, will trigger similar dramatic effects in the clinic.  The immunotherapeutic nanotech gel, deposited at the time of surgery at the site of tumor removal, continually activates the body’s cancer-killing immunity in the regions most likely to harbor “machine-gun nests” of metastatic cells that could grow and kill the host.

 

https://medcitynews.com/2022/10/harvard-spinout-surge-emerges-with-26m-to-make-immunotherapy-part-of-cancer-surgery/

 

#immunotherapy #gel #metastasis #cancer